oleanolic acid has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y; Kinemuchi, H; Kisara, K; Nakahata, N; Ohizumi, Y; Oshima, Y; Subarnas, A; Tadano, T | 1 |
| Daniels, WM; Mabandla, MV; Nyoka, M | 1 |
| Daniels, WM; Mabandla, MV; Ndlovu, BC | 1 |
3 other study(ies) available for oleanolic acid and oxidopamine
| Article | Year |
|---|---|
A possible mechanism of antidepressant activity of beta-amyrin palmitate isolated from Lobelia inflata leaves in the forced swimming test.
Topics: Animals; Antidepressive Agents; Desipramine; Immobilization; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Nomifensine; Norepinephrine; Oleanolic Acid; Oxidopamine; Plant Extracts; Swimming; Synaptosomes; Tetrabenazine; Triterpenes; Tritium | 1993 |
Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
Topics: Animals; Antiparkinson Agents; Apoptosis; Corpus Striatum; Dopamine; Forelimb; Functional Laterality; Male; Medial Forebrain Bundle; Membrane Potential, Mitochondrial; Mitochondria; Motor Activity; Nerve Degeneration; Neuroprotective Agents; Oleanolic Acid; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2015 |
Amelioration of L-Dopa-Associated Dyskinesias with Triterpenoic Acid in a Parkinsonian Rat Model.
Topics: Adrenergic Agents; Age Factors; Animals; Animals, Newborn; Antiparkinson Agents; Catalase; Disease Models, Animal; Dyskinesia, Drug-Induced; Extremities; Female; Glutathione; Levodopa; Male; Movement; Oleanolic Acid; Oxidopamine; Parkinsonian Disorders; Pregnancy; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2016 |